DOI: 10.1055/s-00000011

DMW - Deutsche Medizinische Wochenschrift

LinksClose Window

References

Buske C, Hoster E, Dreyling M. et al.
The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome.

Blood 2006;
108: 1504-1508

Download Bibliographical Data

Access:
Access:

We do not assume any responsibility for the contents of the web pages of other providers.